X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,878 | -84.3% | 143,007 | -72.1% | 0.00% | – |
| Q2 2023 | $993,546 | +243.1% | 512,137 | +53.9% | 0.00% | – |
| Q1 2023 | $289,577 | +109.7% | 332,847 | +138.6% | 0.00% | – |
| Q4 2022 | $138,105 | -50.5% | 139,500 | -14.4% | 0.00% | – |
| Q3 2022 | $279,000 | +142.6% | 162,997 | +148.1% | 0.00% | – |
| Q1 2022 | $115,000 | -88.0% | 65,702 | -84.3% | 0.00% | – |
| Q4 2021 | $956,000 | -5.2% | 418,142 | +119.5% | 0.00% | – |
| Q3 2021 | $1,008,000 | +298.4% | 190,531 | +389.8% | 0.00% | – |
| Q2 2021 | $253,000 | -2.3% | 38,900 | +90.7% | 0.00% | – |
| Q3 2019 | $259,000 | -50.9% | 20,403 | -42.0% | 0.00% | – |
| Q2 2019 | $527,000 | – | 35,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |